Latest Breaking News On - சிறுநீர் பாதை நோய்த்தொற்றுகள் - Page 12 : comparemela.com

Mar 15 2021 MELBOURNE, Australia, March 15, 2021 /PRNewswire/ SuperTrans Medical has announced the appointment of three Australian companies to play pivotal roles in an upcoming clinical drug trial that offers new hope in the plight against antimicrobial resistance (AMR), which the World Health Organisation (WHO) describes as a ‘silent pandemic’ and one of the biggest threats to global health. International biopharmaceutical company SuperTrans Medical has announced the appointment of CMAX, Avance Clinical and Agilex Biolabs as its key clinical research partners to conduct the roll-out of Phase 1 human clinical trials in Australia during 2021 for its revolutionary new antibiotic.    The drug uses SuperTrans Medical’s patented Intelligent Repurposing™ technology, originally invented at Stanford University. This approach involves the chemical attachment of a permeator unit to an existing mainstay antibiotic, which leads to its ‘revitalisation’ by enabling it to effec

South australiaYvonne lungershausenStephen pattersonSepehr shakibLewis nevilleAgilex biolabsJason valentineSupertrans medical limitedIndustries sector planClinical researchStanford universityWorld health organisationSupertrans medicalAvance clinicalIntelligent repurposingAntimicrobial agents